1000 urine samples sought to perfect bladder cancer detection

NCT ID NCT07514143

Recruiting now Knowledge-focused Sponsor: Nucleix Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects urine samples from 1000 adults who may have bladder cancer or are being monitored for it. Researchers will use the samples to improve a test called Bladder EpiCheck. Participants provide one urine sample and share basic health information. The goal is to make bladder cancer detection easier and more accurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NMIBC SURVEILLANCE SUSPICION OF BLADDER CANCER

Contacts and locations

Locations

Chesapeake Urology Research Associates
RECRUITING

Towson, Maryland, 21204, United States
Om Research LLC
RECRUITING

San Diego, California, 92103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.